Related Experiment Video
Updated: Mar 31, 2026
Non-Viral Engineering of Primary Human T Cells via Homology-Mediated End-Joining Targeted Integration of Large DNA Templates
Published on: May 9, 2025
New Strategies in Engineering T-cell Receptor Gene-Modified T cells to More Effectively Target Malignancies
Thomas M Schmitt1, Ingunn M Stromnes2, Aude G Chapuis1
1Clinical Research Division, Program in Immunology, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Abstract:
The immune system, T cells in particular, have the ability to target and destroy malignant cells. However, antitumor immune responses induced from the endogenous T-cell repertoire are often insufficient for the eradication of established tumors, as illustrated by the failure of cancer vaccination strategies or checkpoint blockade for most tumors. Genetic modification of T cells to express a defined T-cell receptor (TCR) can provide the means to rapidly generate large numbers of tumor-reactive T cells capable of targeting tumor cells in vivo. However, cell-intrinsic factors as well as immunosuppressive factors in the tumor microenvironment can limit the function of such gene-modified T cells. New strategies currently being developed are refining and enhancing this approach, resulting in cellular therapies that more effectively target tumors and that are less susceptible to tumor immune evasion.
Insights
T cells can fight cancer, but often fail against established tumors. Genetically engineered T cells offer a promising cellular therapy to overcome tumor defenses and improve cancer treatment outcomes.
Area of Science:
- Immunology
- Oncology
- Cellular Therapy
Background:
- The immune system, particularly T cells, possesses inherent capabilities to identify and eliminate malignant cells.
- However, endogenous T-cell responses are frequently inadequate for eradicating established tumors, evidenced by limited success with current cancer vaccination and checkpoint blockade strategies.
- Tumor microenvironment factors and intrinsic cellular limitations can impair the effectiveness of antitumor immunity.
Purpose of the Study:
- To explore the potential of genetically modified T cells expressing defined T-cell receptors (TCRs) for generating robust antitumor responses.
- To investigate strategies for overcoming limitations imposed by the tumor microenvironment and cell-intrinsic factors on gene-modified T cells.
- To highlight advancements in cellular therapies designed for enhanced tumor targeting and resistance to immune evasion.
Main Methods:
- Genetic modification of T cells to express specific T-cell receptors (TCRs).
- In vivo assessment of gene-modified T cells for tumor targeting capabilities.
- Development of novel strategies to enhance T-cell function within the immunosuppressive tumor microenvironment.
Main Results:
- Genetically engineered T cells can be rapidly generated in large numbers to target tumor cells effectively in vivo.
- Identified cell-intrinsic and tumor microenvironment-related factors that can limit the function of gene-modified T cells.
- Emerging strategies are being developed to improve the efficacy and resilience of these cellular therapies against tumor immune evasion.
Conclusions:
- Engineered T cells represent a powerful approach to augment antitumor immunity.
- Overcoming tumor-induced immunosuppression is critical for the success of T-cell-based cancer therapies.
- Ongoing research focuses on refining cellular therapies for more effective and durable cancer treatment.
More Related Videos
09:56A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
09:29Clinical Application of Sleeping Beauty and Artificial Antigen Presenting Cells to Genetically Modify T Cells from Peripheral and Umbilical Cord Blood
Published on: February 1, 2013
Related Concept Videos
01:27Tumor Immunotherapy
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
01:27Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...